Relating acute esophagitis to radiotherapy dose using FDG-PET in concurrent chemo-radiotherapy for locally advanced non-small cell lung cancer

被引:38
|
作者
Nijkamp, Jasper [1 ]
Rossi, Maddalena [1 ]
Lebesque, Joos [1 ]
Belderbos, Jose [1 ]
van den Heuvel, Michel [2 ]
Kwint, Margriet [1 ]
Uyterlinde, Wilma [2 ]
Vogel, Wouter [1 ,2 ]
Sonke, Jan-Jakob [1 ]
机构
[1] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Radiat Oncoloyg, NL-1066 CX Amsterdam, Netherlands
[2] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, NL-1066 CX Amsterdam, Netherlands
关键词
Acute esophagitis; Concurrent chemo-radiotherapy; NTCP; FDG-PET; MODULATED RADIATION-THERAPY; PULMONARY-FUNCTION; COMPLICATION PROBABILITY; TOXICITY; INFLAMMATION; PNEUMONITIS; IRRADIATION; PARAMETERS; MODELS;
D O I
10.1016/j.radonc.2012.09.024
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To correlate radiotherapy (RT) dose to acute esophagitis (AE) by means of FDG-PET scans acquired after concurrent chemo-radiotherapy (cCRT) for locally advanced non-small-cell lung cancer (NSCLC). Materials and methods: Patients treated with 24 x 2.75 Gy were selected on presence of a post-RT PET (PETpost) scan acquired within 3 months after cCRT. The value of PETpost in relation to AE was evaluated by comparing the mean esophageal SUV of the highest 50% (< SUV50%>) between gr < 2 and gr >= 2AE. The local dose on the esophagus wall was correlated to the SUV and modeled using a power-law fit. The Lyman-Kutcher-Burman (LKB) model was used to predict gr >= 2AE. The local dose-response relation was used in the LKB model to calculate the EUD. Resulting prediction accuracy was compared to D-mean. V-35, V-55 and V-60. Results: Eighty-two patients were included (gr < 2 = 25, gr >= 2 = 57). The (SUV50%) was significantly higher for gr >= 2AE (2.2 vs. 2.6, p < 0.01). The LKB parameters (95% CI) were n = 0.130 (0.120-0.141), m = 0.25 (0.13-0.85) and TD50 = 50.4 Gy (37.5-55.4), which resulted in improved predictability of AE compared to other predictors. Conclusion: Esophageal uptake of FDG post-cCRT reflects AE severity. Predictability of grade >= 2AE was improved by using the local dose-SUV response model, with narrow confidence intervals for the optimized LKB parameters. (C) 2012 Elsevier Ireland Ltd. All rights reserved. Radiotherapy and Oncology 106 (2013) 118-123
引用
收藏
页码:118 / 123
页数:6
相关论文
共 50 条
  • [2] Esophagitis identified in restaging FDG-PET after radiotherapy or chemo-radiotherapy in lung cancer
    Chun, T. T.
    Fischman, A. J.
    Ancukiewicz, M.
    Niemierko, A.
    Fidias, P. M.
    Lynch, T. J.
    Choi, N. C.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S453 - S454
  • [3] Use of chemo-radiotherapy in locally advanced non-small cell lung cancer
    Novello, S
    Le Chevalier, T
    [J]. EUROPEAN JOURNAL OF CANCER, 2002, 38 (02) : 292 - 299
  • [4] Immunological Biomarkers Characterization in Locally Advanced Non-Small Cell Lung Cancer Treated with Concurrent Chemo-Radiotherapy
    Saigi, M.
    Baixeras, N.
    Rullan, A.
    Bergamino Sirven, M.
    Navarro-Martin, A.
    Arnaiz, M.
    Ruffinelli, J. C.
    Mesia, C.
    Palmero, R.
    Padrones, S.
    Cardenal, F.
    Sanchez-Cespedes, M.
    Nadal, E.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2155 - S2155
  • [5] RADIOTHERAPY DOSE, FDG-PET UTILIZATION AND SURVIVAL OUTCOMES OF UNRESECTED LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER (LA-NSCLC). ONTARIO POPULATION OUTCOMES OF CONTEMPORARY RADIOTHERAPY ALONE AND STANDARD OF CARE CHEMO-RADIOTHERAPY
    Gouran-savadkoohi, Mohammad
    Mesci, Aruz
    Pond, Greg
    Swaminath, Anand
    Quan, Kimmen
    Wright, James
    Tsakiridis, Theos
    [J]. RADIOTHERAPY AND ONCOLOGY, 2022, 174 : S59 - S60
  • [6] Feasibility of FDG-PET/CT imaging during concurrent chemo-radiotherapy in patients with locally advanced pancreatic cancer
    Bjerregaard, Jon K.
    Fischer, Barbara M.
    Vilstrup, Mie H.
    Petersen, Henrik
    Mortensen, Michael B.
    Hansen, Christian R.
    Asmussen, Jon T.
    Pfeiffer, Per
    Hoilund-Carlsen, Poul F.
    [J]. ACTA ONCOLOGICA, 2011, 50 (08) : 1250 - 1252
  • [7] Concurrent chemo-radiotherapy in locally advanced non-small cell lung cancer (NSCLC): A multicenter randomized phase II study
    Bouillet, T
    Diana, C
    Pailler, M
    Gozy, M
    Labrune, S
    Gervais, R
    Brechot, J
    Breau, J
    Chinet, T
    Morere, J
    [J]. LUNG CANCER, 2005, 49 : S166 - S167
  • [8] Sequential chemo-radiotherapy in non-small cell lung cancer
    Kotas, M
    Willner, J
    Flentje, M
    [J]. LUNG CANCER, 2001, 33 : S61 - S64
  • [9] Concurrent chemo-radiotherapy in non-small cell lung cancer: preliminary clinical outcomes
    Karakaya, E.
    Franks, K. N.
    Snee, M.
    Clarke, K.
    Turner, R.
    Stuart, R.
    Murray, L. J.
    [J]. LUNG CANCER, 2013, 79 : S63 - S63
  • [10] Role of Consolidation Chemotherapy after Concurrent Chemo-Radiotherapy in Locally Advanced Non-Small-Cell Lung Cancer
    Tsujino, Kazuyuki
    Kurata, Takayasu
    Kawaguchi, Tomoya
    Kubo, Akihito
    Takada, Minoru
    Ando, Masahiko
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (01) : E7 - E8